论文信息 - ME-401-003 (TIDAL): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Phase 2 Study of ME-401 Investigating Continuous and Intermittent Dosing Schedules in Patients with Relapsed/Refractory Follicular Lymphoma - 字舞流文

ME-401-003 (TIDAL): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Phase 2 Study of ME-401 Investigating Continuous and Intermittent Dosing Schedules in Patients with Relapsed/Refractory Follicular Lymphoma

A. Zelenetz | P. Abrisqueta | C. Buske | P. Zinzani | D. Cunningham | Jennifer R. Brown | V. Ribrag | W. Jurczak | Henry S H Chan | I. Gorbatchevsky | Joanne Li